melanoma stage iii

Showing 1 - 25 of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Liquid Biopsy, Melanoma (Skin), Melanoma Stage III Trial in Rome (Affinity Mediated Transport Amplification (AMT))

Recruiting
  • Liquid Biopsy
  • +4 more
  • Affinity Mediated Transport Amplification (AMT)
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jul 13, 2023

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

Recruiting
  • Melanoma Stage III
  • In-Transit Metastasis of Cutaneous Melanoma
  • Encorafenib + Binimetinib
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Mar 2, 2023

Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

Recruiting
  • Resectable Melanoma
  • +2 more
  • BCD-217
  • +3 more
  • Lesnoy, Belarus
  • +35 more
Feb 21, 2023

Melanoma, Melanoma (Skin), Melanoma Stage III Trial in Belarus, India, Russian Federation (BCD-217, BCD-100, Placebo)

Recruiting
  • Melanoma
  • +6 more
  • BCD-217
  • +2 more
  • Babruysk, Belarus
  • +62 more
Feb 8, 2023

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • (no location specified)
Dec 14, 2022

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

Recruiting
  • Malignant Melanoma
  • +3 more
  • SCIB1 DNA vaccine
  • Cardiff, United Kingdom
  • +6 more
Dec 7, 2022

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Unmet Needs and Attitudes to Skin Self-examination in Melanoma

Completed
  • Melanoma, Stage I
  • +2 more
  • Questionnaire
  • Headington, Oxford, United Kingdom
    Churchill Hospital
Nov 19, 2022

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma Trial in Worldwide (BNT111, Cemiplimab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • BNT111
  • Cemiplimab
  • Tucson, Arizona
  • +53 more
Aug 24, 2022

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

Melanoma, Stage I, Melanoma, Stage II, Melanoma Stage III Trial (MSOT)

Not yet recruiting
  • Melanoma, Stage I
  • +2 more
  • MSOT
  • (no location specified)
Jul 15, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (Fecal microbiota transplantation)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Fecal microbiota transplantation
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Jul 8, 2022

Conservative Nodal Surgery of Stage III Melanoma With Low-burden

Recruiting
  • Melanoma Stage III
    • Seville, Spain
      Dermatology Department. University Hospital Virgen Macarena
    Jun 30, 2022

    Melanoma, Melanoma Stage III Trial in New York (diagnostic test, drug, procedure)

    Recruiting
    • Melanoma
    • Melanoma Stage III
    • PET Scan
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Jun 24, 2022

    Patients With Stage 0-IV Melanoma in Real Clinical Practice

    Recruiting
    • Melanoma
    • +7 more
    • surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
    • Moscow, Russian Federation
      N.N. Blokhin Russian Cancer Research Center
    Jun 12, 2022

    metAsTatI? melanOma Treated With dabrafeNib and trAmetinib in

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Barnaul, Alatai, Russian Federation
    • +14 more
    May 29, 2022

    Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Encorafenib Pill
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    May 27, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in Jette (Regorafenib 40 MG Oral Tablet)

    Not yet recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Regorafenib 40 MG Oral Tablet
    • Jette, Brussel, Belgium
      UZ Brussels
    May 6, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in Wollstonecraft, Nedlands (EVX-01, Pembrolizumab 25 MG/ML)

    Not yet recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Wollstonecraft, New South Wales, Australia
    • +2 more
    May 11, 2022

    Melanoma Stage Iv, Melanoma Stage Iii, Melanoma Trial in Australia (Denosumab, Nivolumab, Ipilimumab)

    Active, not recruiting
    • Melanoma Stage Iv
    • +2 more
    • Albury, New South Wales, Australia
    • +9 more
    Apr 6, 2022